|
|
||||||||
From the Service de Neurologie (Dr. Biraben), CHU Pontchaillou, Rennes; Service Hospitalier Frédéric Joliot (Drs. Semah, Ribeiro, and Remy, and G. Douaud), CEA, Orsay; Service de Neurologie (Dr. Remy), CHU Henri Mondor et Université Paris 12, Créteil; and JE 2413Université Joseph Fourier (Dr. Depaulis), Grenoble, France.
Address correspondence and reprint requests to Dr. Arnaud Biraben, Service de Neurologie, Hôpital Pontchaillou, 35033 Rennes Cedex, France; e-mail: arnaud.biraben{at}chu-rennes.fr
Background: Studies in animal models and epileptic patients have suggested that circuits of the basal ganglia may control epileptic seizures and that striatal dopaminergic transmission plays a key role in seizure interruption. Ring chromosome 20 (r[20]) epilepsy is a very homogenous type of epilepsy and is clinically characterized by long-lasting seizures suggesting a dysfunction in the seizure control system. The hypothesis that these long-lasting seizures are associated with a reduction of striatal dopamine was addressed in the present study in drug-resistant patients with r(20) epilepsy using PET.
Method: The authors performed [18F]fluoro-L-DOPA PET in 14 patients with r(20) epilepsy and compared uptake constants in the putamen and the caudate with those of 10 controls. In addition, the authors examined the correlation between these constants and the percentage of cells with r(20) mosaicism.
Results: [18F]fluoro-L-DOPA uptake was significantly decreased bilaterally in the putamen and in the caudate nucleus of patients. This reduction was equal for both nuclei and was not correlated to the percentage of cells with r(20).
Conclusion: Striatal dopamine is modulated in r(20) epilepsy; dysfunction of this neurotransmission may impair the mechanisms that interrupt seizures.
Received September 8, 2003. Accepted in final form February 24, 2004.
This article has been cited by other articles:
![]() |
S. R. Haut and R. L. Albin Dopamine and epilepsy: Hints of complex subcortical roles Neurology, September 9, 2008; 71(11): 784 - 785. [Full Text] [PDF] |
||||
![]() |
C. Ciumas, T-B R. Wahlin, A. Jucaite, P. Lindstrom, C. Halldin, and I. Savic Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy Neurology, September 9, 2008; 71(11): 788 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Darbin and T. Wichmann Effects of Striatal GABAA-Receptor Blockade on Striatal and Cortical Activity in Monkeys J Neurophysiol, March 1, 2008; 99(3): 1294 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bouilleret, F. Semah, F. Chassoux, M. Mantzaridez, A. Biraben, R. Trebossen, and M. -J. Ribeiro Basal ganglia involvement in temporal lobe epilepsy: A functional and morphologic study Neurology, January 15, 2008; 70(3): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bouilleret, F. Semah, A. Biraben, D. Taussig, F. Chassoux, A. Syrota, and M.-J. Ribeiro Involvement of the Basal Ganglia in Refractory Epilepsy: An 18F-Fluoro-L-DOPA PET Study Using 2 Methods of Analysis J. Nucl. Med., March 1, 2005; 46(3): 540 - 547. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |